These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 28817119

  • 21. Down-regulation of microRNA-338-3p promoted angiogenesis in hepatocellular carcinoma.
    Zhang T, Liu W, Zeng XC, Jiang N, Fu BS, Guo Y, Yi HM, Li H, Zhang Q, Chen WJ, Chen GH.
    Biomed Pharmacother; 2016 Dec; 84():583-591. PubMed ID: 27694002
    [Abstract] [Full Text] [Related]

  • 22. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling.
    Zhao YR, Wang JL, Xu C, Li YM, Sun B, Yang LY.
    Clin Sci (Lond); 2019 Jul 31; 133(14):1645-1662. PubMed ID: 31278131
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. miR-29a-SIRT1-Wnt/β-Catenin Axis Regulates Tumor Progression and Survival in Hepatocellular Carcinoma.
    Qian L, Zhang Y, Wang G, Li B, Zhou H, Qiu J, Qin L.
    Biochem Genet; 2024 Jun 31; 62(3):1895-1913. PubMed ID: 37776468
    [Abstract] [Full Text] [Related]

  • 27. LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma.
    Teng F, Zhang JX, Chang QM, Wu XB, Tang WG, Wang JF, Feng JF, Zhang ZP, Hu ZQ.
    J Exp Clin Cancer Res; 2020 Nov 09; 39(1):235. PubMed ID: 33168027
    [Abstract] [Full Text] [Related]

  • 28. MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma.
    Xia H, Ooi LL, Hui KM.
    PLoS One; 2012 Nov 09; 7(9):e44206. PubMed ID: 22962603
    [Abstract] [Full Text] [Related]

  • 29. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R, Yu Z, Chen F, Xu H, Shen S, Chen W, Chen L, Su Q, Zhang L, Bi J, Zeng W, Li W, Huang X, Wang Q.
    Biomed Pharmacother; 2018 Jul 09; 103():1632-1642. PubMed ID: 29864952
    [Abstract] [Full Text] [Related]

  • 30. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
    Quan H, Li B, Yang J.
    Biomed Pharmacother; 2018 Nov 09; 107():754-762. PubMed ID: 30142536
    [Abstract] [Full Text] [Related]

  • 31. MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression.
    Fang JH, Zhou HC, Zeng C, Yang J, Liu Y, Huang X, Zhang JP, Guan XY, Zhuang SM.
    Hepatology; 2011 Nov 09; 54(5):1729-40. PubMed ID: 21793034
    [Abstract] [Full Text] [Related]

  • 32. miR-186 modulates hepatocellular carcinoma cell proliferation and mobility via targeting MCRS1-mediated Wnt/β-catenin signaling.
    Wang H, Ou J, Jian Z, Ou Y.
    J Cell Physiol; 2019 Dec 09; 234(12):23135-23145. PubMed ID: 31140612
    [Abstract] [Full Text] [Related]

  • 33. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.
    Sun J, Liu L, Zou H, Yu W.
    Yonsei Med J; 2019 Oct 09; 60(10):905-913. PubMed ID: 31538425
    [Abstract] [Full Text] [Related]

  • 34. MicroRNA-639 is Down-Regulated in Hepatocellular Carcinoma Tumor Tissue and Inhibits Proliferation and Migration of Human Hepatocellular Carcinoma Cells Through the KAT7/Wnt/β-Catenin Pathway.
    Bai Z, Xia X, Lu J.
    Med Sci Monit; 2020 Jan 19; 26():e919241. PubMed ID: 31955177
    [Abstract] [Full Text] [Related]

  • 35. MiR-425-5p promotes invasion and metastasis of hepatocellular carcinoma cells through SCAI-mediated dysregulation of multiple signaling pathways.
    Fang F, Song T, Zhang T, Cui Y, Zhang G, Xiong Q.
    Oncotarget; 2017 May 09; 8(19):31745-31757. PubMed ID: 28423650
    [Abstract] [Full Text] [Related]

  • 36. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y, Liu Z, Yao B, Li Q, Wang L, Wang C, Dou C, Xu M, Liu Q, Tu K.
    Mol Cancer; 2017 Jul 17; 16(1):123. PubMed ID: 28716020
    [Abstract] [Full Text] [Related]

  • 37. miR-4458 inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing the TGF-β signaling pathway via targeting TGFBR1.
    Zhang Y, Shi K, Liu H, Chen W, Luo Y, Wei X, Wu Z.
    Acta Biochim Biophys Sin (Shanghai); 2020 May 26; 52(5):554-562. PubMed ID: 32324847
    [Abstract] [Full Text] [Related]

  • 38. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H, Xu Q, Xiao S, Wu Z, Gong J, Liu C, Ren G, Wu H.
    Life Sci; 2019 May 01; 224():1-11. PubMed ID: 30876939
    [Abstract] [Full Text] [Related]

  • 39. MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner.
    Huang Z, Wen J, Yu J, Liao J, Liu S, Cai N, Liang H, Chen X, Ding Z, Zhang B.
    J Exp Clin Cancer Res; 2020 Aug 04; 39(1):150. PubMed ID: 32746934
    [Abstract] [Full Text] [Related]

  • 40. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
    Cao F, Yin LX.
    Exp Mol Pathol; 2019 Feb 04; 106():34-43. PubMed ID: 30539797
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.